Causes of Colitis
Colitis is primarily caused by environmental triggers (infections, drugs, or other agents) in genetically susceptible individuals, with different types having distinct pathophysiological mechanisms. 1
Types and Causes of Colitis
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis (UC)
- Environmental triggers in genetically susceptible individuals 1
- Genetic component present but weaker than in Crohn's disease 1
- Smoking paradoxically decreases risk (opposite effect compared to Crohn's) 1
- Characterized by superficial mucosal ulceration limited to the colon 2
- Affects the colon in a retrograde and continuous fashion starting from the rectum 2
Crohn's Disease (Colonic form)
Microscopic Colitis
Medication-induced triggers:
Risk factors:
Immune Checkpoint Inhibitor (ICPi) Colitis
- Caused by immune checkpoint inhibitor therapy 1
- Often affects descending colon more than other parts 1
- Histologically shows more inflammatory changes than classic IBD 1
- Characterized by marked mixed inflammatory cell infiltrates 1
Infectious Colitis
- Common pathogens to exclude:
Pathophysiological Mechanisms
Immune-Mediated Processes
- Loss of tolerance against indigenous enteric flora is the central event in IBD pathogenesis 5
- Abnormalities in humoral and cell-mediated immunity 5
- Enhanced reactivity against intestinal bacterial antigens 5
- Defects in regulatory T-cell function 5
- Excessive stimulation of mucosal dendritic cells 5
Inflammatory Pathways
Autoimmune Components
- Presence of serum and mucosal autoantibodies against intestinal epithelial cells 5
- Perinuclear antineutrophil cytoplasmic antibodies (pANCA) common in UC 5
- Antibodies against Saccharomyces cerevisiae (ASCA) frequently found in Crohn's disease 5
Risk Factors for Opportunistic Infections in IBD
- Immunosuppressive treatments (particularly in combination) 1
- Malnutrition and obese BMI 1
- Comorbidities 1
- Active disease 1
- Older age 1
- Combination therapies (especially thiopurines plus steroids or thiopurines plus steroids plus infliximab) 1
Clinical Evaluation for Suspected Colitis
Key History Elements
- Onset of symptoms, rectal bleeding, stool consistency and frequency 1
- Urgency, tenesmus, abdominal pain, incontinence, nocturnal diarrhea 1
- Recent travel, possible infectious exposures 1
- Medication history (antibiotics, NSAIDs, immunosuppressants) 1, 3
- Smoking status 1
- Family history of IBD or colorectal cancer 1
Initial Investigations
- Full blood count, inflammatory markers (CRP, ESR) 1
- Electrolytes and liver function tests 1
- Stool samples for microbiological analysis (including C. difficile toxin) 1
- Faecal calprotectin (accurate marker of colonic inflammation) 1
- Endoscopy with histological analysis 1
Important Clinical Considerations
- No single "gold standard" exists for diagnosing colitis - diagnosis is established by clinical, laboratory, imaging, and endoscopic parameters 1
- Infectious causes must always be excluded before confirming inflammatory colitis 1
- Autoimmune diseases are significantly associated with microscopic colitis (22% vs 11% in controls) 4
- Combination immunosuppressive therapies significantly increase risk of opportunistic infections 1
- Microscopic colitis can coexist with other conditions like bile acid diarrhea 3